Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Walter Noot, Chief Operating Officer of USANA Health Sciences Inc . (NYSE:USNA), recently sold a portion of his holdings in the company. According to a recent filing, Noot sold 6,291 shares of common stock on May 27, 2025, at an average price of $30.2921 per share. This transaction totaled approximately $190,567. Following the sale, Noot holds no shares of USANA stock. The stock was sold at prices ranging from $30.25 to $30.39 per share.The transaction occurred as USANA, with a market capitalization of $555 million, trades near its 52-week low of $23.10. InvestingPro analysis indicates the stock is currently undervalued, despite a challenging year with a 36% decline. The company maintains a "GOOD" Financial Health score, supported by strong fundamentals including an impressive 80.5% gross margin and minimal debt.
In other recent news, USANA Health Sciences announced its Q1 2025 earnings, showing a notable financial performance. The company reported earnings per share (EPS) of 0.73, which was slightly below the expected 0.8, but surpassed revenue expectations with 250 million dollars compared to the forecasted 243.15 million dollars. This revenue increase was largely driven by a 64% surge in net sales in Mainland China. The company has also seen positive developments following its acquisition of Hyatt, contributing to its competitive position in the health and wellness sector. Analysts from Sidoti and Company highlighted USANA’s strategic initiatives in China, including product promotions and leadership events that have helped drive sales growth. The firm also plans to introduce new products and strategic partnerships in the latter half of 2025, focusing on children’s health and wellness. Despite potential challenges like geopolitical tensions and tariff impacts, USANA remains optimistic about its growth trajectory. The company has proactively managed its supply chain to mitigate tariff exposure and continues to explore alternate sourcing strategies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.